We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SQZ
3676
DELISTED
SQZ Biotechnologies Company
SQZ
$84K ﹤0.01%
114,028
+55,425
+95% +$121K
ATHX
3677
DELISTED
Athersys, Inc. Common Stock
ATHX
$84K ﹤0.01%
99,936
+40,200
+67% +$50K
GP
3678
GreenPower Motor Co
GP
$10.8M
$83K ﹤0.01%
4,800
-20,272
-81% -$455K
SANW
3679
DELISTED
S&W Seed Co
SANW
$83K ﹤0.01%
2,917
-84
-3% -$1.68K
SNOA icon
3680
Sonoma Pharmaceuticals
SNOA
$5.74M
$83K ﹤0.01%
3,723
-45
-1% -$1.6K
ORKA
3681
Oruka Therapeutics
ORKA
$5.92B
$83K ﹤0.01%
2,933
+141
+5% +$3.61K
ABUS icon
3682
Arbutus Biopharma
ABUS
$873M
$82K ﹤0.01%
35,136
-10,524
-23% -$25.2K
JAGX icon
3683
Jaguar Health
JAGX
$4.91M
0
XCUR icon
3684
Exicure
XCUR
$9.82M
$82K ﹤0.01%
14,320
-1,640
-10% -$10.2K
MNDO icon
3685
Mind CTI
MNDO
$21M
$81K ﹤0.01%
38,500
+18,000
+88% +$38.4K
OPAD icon
3686
Offerpad Solutions
OPAD
$23.5M
$81K ﹤0.01%
1,166
-272
-19% -$31.4K
MDNA
3687
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$81K ﹤0.01%
176,542
+131,142
+289% +$80.1K
CBUS icon
3688
Cibus
CBUS
$147M
$80K ﹤0.01%
10,913
-192
-2% -$1.49K
CLRB icon
3689
Cellectar Biosciences
CLRB
$20.5M
$80K ﹤0.01%
1,558
+968
+164% +$58K
GNPX icon
3690
Genprex
GNPX
$2.23M
$80K ﹤0.01%
1
-1
-50% -$56.5K
BRMK
3691
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$80K ﹤0.01%
22,400
-124,500
-85% -$580K
CALC icon
3692
CalciMedica
CALC
$12.6M
$78K ﹤0.01%
11,143
-3,178
-22% -$35.6K
LPCN icon
3693
Lipocine
LPCN
$17.6M
$78K ﹤0.01%
11,547
-182
-2% -$1.33K
BVC
3694
BitVentures Limited Ordinary Shares
BVC
$1.96B
$78K ﹤0.01%
13,700
-700
-5% -$4.2K
FRMM
3695
Forum Markets
FRMM
$77.1M
$77K ﹤0.01%
120
+87
+264% +$131K
AUST icon
3696
Austin Gold Corp
AUST
$14.9M
$77K ﹤0.01%
81,122
+39,430
+95% +$38.2K
AMS icon
3697
American Shared Hospital Services
AMS
$9.8M
$76K ﹤0.01%
26,000
+6,679
+35% +$18.5K
DRIO icon
3698
DarioHealth
DRIO
$67M
$76K ﹤0.01%
+890
New +$80.1K
FEDU
3699
Four Seasons Education Depositary Shares Rep 10 Ordinary Shares
FEDU
$18.1M
$76K ﹤0.01%
10,512
-2,615
-20% -$22.6K
TFFP
3700
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$76K ﹤0.01%
+2,886
New +$137K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.